Qunxing Li,md
Clinical trials sponsored by Qunxing Li,md, explained in plain language.
-
Could smaller surgery after immunotherapy spare head and neck cancer patients?
Disease control Recruiting nowThis study compares a less extensive surgery (de-escalated) to standard surgery for people with advanced head and neck cancer who have already responded well to immunotherapy and chemotherapy. The goal is to see if the smaller surgery can control the cancer just as well while imp…
Phase: NA • Sponsor: Qunxing Li,MD • Aim: Disease control
Last updated May 26, 2026 08:30 UTC
-
Immunotherapy combo shows promise in fighting advanced oral cancer
Disease control Recruiting nowThis study tests whether adding the immunotherapy drug sintilimab to standard chemotherapy before and after surgery can help people with advanced oral cancer live longer without the cancer coming back. About 104 adults with stage III or IV oral cancer will be randomly assigned to…
Phase: PHASE3 • Sponsor: Qunxing Li,MD • Aim: Disease control
Last updated May 20, 2026 11:56 UTC